Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: SGLT2i Mar 13 | 2019Lexicon Quiet on Sota T1DM Review; Q4 '18 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring Mar 12 | 2019New Eversense Bridge Program; Senseonics Q4 '18 Earnings UpdatePurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Other Mar 12 | 2019Adocia Q4 '18 Earnings Update; No Call ConductedPurchase Blast
$599
Posted in: Other Mar 12 | 2019Zafgen Q4 '18 Earnings Update; ZGN-1258 Discontinued in PWSPurchase Blast
$599
Posted in: DPP-IVi, Dual/triple agonist, GLP-1RA, Other, SGLT2i Mar 11 | 2019New Head of AZ CVRMPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery Mar 08 | 2019Thoughts on Potential Livongo IPOPurchase Blast
$599
Posted in: Glucose Monitoring Mar 07 | 2019Dexcom Loses Appeals Court Bid For AgaMatrix LawsuitPurchase Blast
$599
Posted in: Basal Insulin Mar 06 | 2019Thoughts on Biocon Form 483 Observations and Impact to Semglee US LaunchPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Mar 05 | 2019New Glooko Business Model; Glooko Mobile App to be Given Away for FreePurchase Blast
$599
Posted in: Bolus Insulin, Insulin Delivery Mar 04 | 2019Thoughts on Lilly’s Humalog Authorized GenericPurchase Blast
$599
Posted in: Bolus Insulin Mar 01 | 2019Fiasp Pediatric Indication Filed in US and EUPurchase Blast
$599
Posted in: SGLT2i Mar 01 | 2019Sota/Dapa T1DM EU Regulatory Analysis; Sota Receives Positive CHMP OpinionPurchase Blast
$599
Posted in: GLP-1RA + Basal Feb 28 | 2019Xultophy Label Update at Parity with SoliquaPurchase Blast
$599
Posted in: Basal Insulin, GLP-1RA, GLP-1RA + Basal Feb 27 | 2019Soliqua Label Update More Competitive vs. Xultophy and BasaglarPurchase Blast
$599
Posted in: Basal Insulin, Insulin Delivery Feb 26 | 2019Tandem and Mylan Q4 '18 Earnings UpdatesPurchase Blast